Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following PD-1 Checkpoint Blockade

This case report describes man in his 60s who presented with a maxillary sinus squamous cell carcinoma and experienced hyperprogression following treatment with pembrolizumab.
Source: JAMA Otolaryngology - Head and Neck Surgery - Category: ENT & OMF Source Type: research